Mississippi 2025 Regular Session Status: Passed Senate Bipartisan · 15 R · 1 D cosponsors

SB 2677 — Pharmacy Benefit Prompt Pay Act; define requirements for pharmacy benefit managers and pharmacy services administrative organizations.

Last action — Died In Committee

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2025 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

456 added · 454 removed

Plain-language change summary

The updated version of SB 2677 introduces several changes to the Pharmacy Benefit Prompt Pay Act. Key amendments include adding requirements for pharmacy benefit managers (PBMs) to make prompt payments to pharmacies and to establish a fair process for pharmacies to appeal low reimbursement rates. Additionally, it prohibits PBMs from practices that can inflate drug prices, termed "spread pricing." These changes aim to ensure that pharmacies are compensated fairly and promptly for their services, which is important for maintaining access to medications for patients.

→
Previous
Latest
Public Health and Parker, Williams, Berry, Chassaniol, Welfare McCaughn, Hopson, Blackwell, McLendon, Rhodes, Barrett COMMITTEE SUBSTITUTE FOR SENATE BILL NO.
Public Health and Parker, Williams, Berry, Chassaniol, Welfare McCaughn, Hopson, Blackwell, McLendon, Rhodes, Barrett, Boyd, Butler, Seymour SENATE BILL NO.
2677 AN ACT TO AMEND SECTION 73-21-151, MISSISSIPPI CODE OF 1972, TO REFERENCE NEW SECTIONS IN THE PHARMACY BENEFIT PROMPT PAY ACT;
2677 (As Passed the Senate) AN ACT TO AMEND SECTION 73-21-151, MISSISSIPPI CODE OF 1972, TO REFERENCE NEW SECTIONS IN THE PHARMACY BENEFIT PROMPT PAY ACT;
2677 *SS08/R857CS.1* ~ OFFICIAL ~ G3/5 25/SS08/R857CS.1 PAGE 1 NOT APPLY TO FACILITIES LICENSED TO FILL PRESCRIPTIONS SOLELY FOR EMPLOYEES OF A PLAN SPONSOR OR EMPLOYER;
2677 *SS36/R857PS* ~ OFFICIAL ~ G3/5 25/SS36/R857PS PAGE 1 NOT APPLY TO FACILITIES LICENSED TO FILL PRESCRIPTIONS SOLELY FOR EMPLOYEES OF A PLAN SPONSOR OR EMPLOYER;
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 2 (a) "Board" means the * * * Mississippi Board of Pharmacy.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 2 (a) "Board" means the * * * Mississippi Board of Pharmacy.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 3 ( * * *h) "Health insurance plan" means benefits consisting of prescription drugs, other products and supplies, and pharmacist services provided directly, through insurance or reimbursement, or otherwise and including items and services paid for as prescription drugs, other products and supplies, and pharmacist services under any hospital or medical service policy or certificate, hospital or medical service plan contract, preferred provider organization agreement, or health maintenance organization contract offered by a health insurance issuer.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 3 ( * * *h) "Health insurance plan" means benefits consisting of prescription drugs, other products and supplies, and pharmacist services provided directly, through insurance or reimbursement, or otherwise and including items and services paid for as prescription drugs, other products and supplies, and pharmacist services under any hospital or medical service policy or certificate, hospital or medical service plan contract, preferred provider organization agreement, or health maintenance organization contract offered by a health insurance issuer.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 4 (* * *l) "Pharmacy benefit manager" * * * means an entity that provides pharmacy benefit management services.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 4 (* * *l) "Pharmacy benefit manager" * * * means an entity that provides pharmacy benefit management services.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 5 (i) Adjudicate drug claims or any portion of the transaction.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 5 (i) Adjudicate drug claims or any portion of the transaction.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 6 pharmacies or pharmacists with credentialing, billing, audit, general business and analytic support.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 6 pharmacies or pharmacists with credentialing, billing, audit, general business and analytic support.
(r) "Plan sponsors" means the employers, insurance companies, unions and health maintenance organizations that contract, either directly or indirectly, with a pharmacy benefit manager for delivery of prescription drugs and/or services.
( * * *r) "Plan sponsors" means the employers, insurance companies, unions and health maintenance organizations that contract, either directly or indirectly, with a pharmacy benefit manager for delivery of prescription drugs and/or services.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 7 other provider on behalf of the health benefit plan, less a pharmacy benefit management or PSAO fee.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 7 other provider on behalf of the health benefit plan, less a pharmacy benefit management or PSAO fee.
* * * (w) "Wholesale acquisition cost" means the wholesale acquisition cost of the drug as defined in 42 USC§ 1395w-3a(c)(6)(B).
(w) "Wholesale acquisition cost" means the wholesale acquisition cost of the drug as defined in 42 USC§ 1395w-3a(c)(6)(B).
(2) Pharmacy benefit managers, their agents and other parties responsible for reimbursement for prescription drugs and S.
(2) Pharmacy benefit managers, their agents and other parties responsible for reimbursement for prescription drugs and other products and supplies shall be required to update the S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 8 other products and supplies shall be required to update the nationally recognized reference prices or amounts used for calculation of reimbursement for prescription drugs and other products and supplies no less than every three (3) business days.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 8 nationally recognized reference prices or amounts used for calculation of reimbursement for prescription drugs and other products and supplies no less than every three (3) business days.
* * * If a written claim is denied, the pharmacy benefit manager shall notify the pharmacy or S.
* * * If a written claim is denied, the pharmacy benefit manager shall notify the pharmacy or pharmacies no later than thirty-five (35) days * * * of receipt of S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 9 pharmacies no later than thirty-five (35) days * * * of receipt of such claim * * *.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 9 such claim * * *.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 10 covered under the terms of a contract or policy of accident and sickness insurance or prepaid coverage.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 10 covered under the terms of a contract or policy of accident and sickness insurance or prepaid coverage.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 11 interest due pursuant to this * * * subsection is less than One Dollar ($1.00), such amount shall be credited to the account of the person or entity to whom such amount is owed.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 11 interest due pursuant to this * * * subsection is less than One Dollar ($1.00), such amount shall be credited to the account of the person or entity to whom such amount is owed.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 12 73-21-156.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 12 73-21-156.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 13 (b) Shall be available for purchase by each pharmacy in the state from national or regional wholesalers operating in Mississippi;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 13 (b) Shall be available for purchase by each pharmacy in the state from national or regional wholesalers operating in Mississippi;
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 14 instructions, including listing any required information to be submitted by pharmacies for the purpose of submitting administrative appeals;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 14 instructions, including listing any required information to be submitted by pharmacies for the purpose of submitting administrative appeals;
and ( * * *iv) A period of less than thirty (30) business days to file an administrative appeal.
and ( * * *iv) A period of no less than thirty (30) * * * days to file an administrative appeal.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 15 (e) The board may adopt rules and regulations necessary to ensure compliance with this subsection.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 15 (e) The board may adopt rules and regulations necessary to ensure compliance with this subsection.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 16 board on a form to be prescribed by the board.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 16 board on a form to be prescribed by the board.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 17 thirty (30) days after the board determines that the information is no longer necessary or useful.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 17 thirty (30) days after the board determines that the information is no longer necessary or useful.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 18 to file such information under current law with the Commissioner of Insurance and allow the pharmacy benefit manager to file a copy of documents containing such information with the board in lieu of the statement required by this section.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 18 to file such information under current law with the Commissioner of Insurance and allow the pharmacy benefit manager to file a copy of documents containing such information with the board in lieu of the statement required by this section.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 19 (b) Acknowledge that spread pricing is not permitted in accordance with this section.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 19 (b) Acknowledge that spread pricing is not permitted in accordance with this section.
(5) This section shall stand repealed on June 30, 2028.
(5) A pharmacy benefit manager or third-party payer shall not charge or cause a patient to pay an amount that exceeds the total amount retained by the pharmacy.
(6) This section shall stand repealed on June 30, 2028.
(a) Directing, ordering * * *, or requiring a patient to use a specific affiliate pharmacy * * * or pharmacies, for the purpose of filling a prescription or receiving services or other care from a pharmacist;
(a) Directing, ordering * * *, or requiring a patient to use a specific affiliate pharmacy * * * or pharmacies, for the S.
(b) Offering or implementing health insurance plan designs that require * * * a beneficiary to * * * utilize an S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 20 affiliate pharmacy or pharmacies, or that increases costs to a patient, including requiring a patient to pay the full cost for a prescription drug when such patient chooses not to use a pharmacy benefit manager affiliate pharmacy;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 20 purpose of filling a prescription or receiving services or other care from a pharmacist;
(b) Offering or implementing health insurance plan designs that require * * * a beneficiary to * * * utilize an affiliate pharmacy or pharmacies, or that increases costs to a patient, including requiring a patient to pay the full cost for a prescription drug when such patient chooses not to use a pharmacy benefit manager affiliate pharmacy;
The term " * * *steering" does not include a pharmacy's inclusion by a pharmacy benefit manager or pharmacy benefit manager affiliate in communications to patients, including patient and prospective patient specific communications, regarding network pharmacies and prices, provided that the pharmacy benefit manager or a pharmacy benefit manager affiliate includes information regarding eligible nonaffiliate pharmacies in those communications and the information provided is accurate.
The term " * * *steering" does not include a pharmacy's inclusion by a pharmacy benefit manager or pharmacy benefit manager affiliate in communications to patients, including patient and prospective patient specific communications, regarding network S.
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 21 (2) A pharmacy, pharmacy benefit manager, or pharmacy benefit manager affiliate licensed or operating in Mississippi shall be prohibited from:
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 21 pharmacies and prices, provided that the pharmacy benefit manager or a pharmacy benefit manager affiliate includes information regarding eligible nonaffiliate pharmacies in those communications and the information provided is accurate.
(2) A pharmacy, pharmacy benefit manager, or pharmacy benefit manager affiliate licensed or operating in Mississippi shall be prohibited from:
or (d) Interfering with the patient's right to choose the patient's pharmacy or provider of choice, including inducement, required referrals or offering financial or other incentives or measures that would constitute a violation of Section 83-9-6.
or (d) Interfering with the patient's right to choose the patient's pharmacy or provider of choice, including inducement, S.
(3) This section shall not be construed to prohibit a pharmacy from entering into an agreement with a pharmacy benefit manager or pharmacy benefit manager affiliate to provide pharmacy S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 22 care to patients, provided that neither the pharmacy * * * nor the pharmacy benefit manager or pharmacy benefit manager affiliate violate subsection (2) of this section and the pharmacy provides the disclosures required in subsection (1) of this section.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 22 required referrals or offering financial or other incentives or measures that would constitute a violation of Section 83-9-6.
(3) This section shall not be construed to prohibit a pharmacy from entering into an agreement with a pharmacy benefit manager or pharmacy benefit manager affiliate to provide pharmacy care to patients, provided that neither the pharmacy * * * nor the pharmacy benefit manager or pharmacy benefit manager affiliate violate subsection (2) of this section and the pharmacy provides the disclosures required in subsection (1) of this section.
Show all 107 changed rows (67 more)
Previous
Latest
(a) A pharmacy benefit manager, pharmacy benefit manager affiliate or PSAO shall not retaliate against a pharmacist or pharmacy based on the pharmacist's or pharmacy's exercise of any right or remedy under this chapter.
(a) A pharmacy benefit manager, pharmacy benefit manager affiliate or PSAO shall not retaliate against a pharmacist S.
Retaliation prohibited by this section includes, but is not limited to:
(i) Terminating or refusing to renew a contract with the pharmacist or pharmacy;
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 23 (ii) Subjecting the pharmacist or pharmacy to an increased frequency of audits, number of claims audited or amount of monies for claims audited;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 23 or pharmacy based on the pharmacist's or pharmacy's exercise of any right or remedy under this chapter.
Retaliation prohibited by this section includes, but is not limited to:
(i) Terminating or refusing to renew a contract with the pharmacist or pharmacy;
(ii) Subjecting the pharmacist or pharmacy to an increased frequency of audits, number of claims audited or amount of monies for claims audited;
(2) A pharmacy benefit manager, pharmacy benefit manager affiliate or PSAO shall not penalize or retaliate against a pharmacist, pharmacy or pharmacy employee for exercising any rights under this chapter, initiating any judicial or regulatory actions or discussing or disclosing information pertaining to an agreement with a pharmacy benefit manager or a pharmacy benefit manager affiliate when testifying or otherwise appearing before any governmental agency, legislative member or body or any judicial authority.
(2) A pharmacy benefit manager, pharmacy benefit manager affiliate or PSAO shall not penalize or retaliate against a pharmacist, pharmacy or pharmacy employee for exercising any rights under this chapter, initiating any judicial or regulatory actions or discussing or disclosing information pertaining to an S.
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 24 SECTION 9.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 24 agreement with a pharmacy benefit manager or a pharmacy benefit manager affiliate when testifying or otherwise appearing before any governmental agency, legislative member or body or any judicial authority.
SECTION 9.
Each day a violation continues for the same brand or generic product identifier or brand or generic code number is a separate violation.
Each day a violation continues for S.
Each day that a pharmacy benefit manager or PSAO does business in this state without a license is deemed a separate violation.
The board shall prepare a S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 25 record entered upon its minutes that states the basic facts upon which the monetary penalty was imposed.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 25 the same brand or generic product identifier or brand or generic code number is a separate violation.
Each day that a pharmacy benefit manager or PSAO does business in this state without a license is deemed a separate violation.
The board shall prepare a record entered upon its minutes that states the basic facts upon which the monetary penalty was imposed.
( * * *5) When payment of a monetary penalty assessed and levied by the board against a licensee, registrant or permit holder in accordance with this section is not paid by the licensee, registrant or permit holder when due under this section, S.
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 26 the board shall have the power to institute and maintain proceedings in its name for enforcement of payment in the chancery court of the county and judicial district of residence of the licensee, registrant or permit holder, or if the licensee, registrant or permit holder is a nonresident of the State of Mississippi, in the Chancery Court of the First Judicial District of Hinds County, Mississippi.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 26 ( * * *5) When payment of a monetary penalty assessed and levied by the board against a licensee, registrant or permit holder in accordance with this section is not paid by the licensee, registrant or permit holder when due under this section, the board shall have the power to institute and maintain proceedings in its name for enforcement of payment in the chancery court of the county and judicial district of residence of the licensee, registrant or permit holder, or if the licensee, registrant or permit holder is a nonresident of the State of Mississippi, in the Chancery Court of the First Judicial District of Hinds County, Mississippi.
(b) If, after the conclusion of the audit, the pharmacy benefit manager or PSAO was found to be in compliance with all of the requirements of this act, then the board shall pay the costs of the audit.
S.
However, the pharmacy benefit manager or PSAO being audited shall pay all costs of such audit if such audit reveals S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 27 any noncompliance with this act.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 27 (b) If, after the conclusion of the audit, the pharmacy benefit manager or PSAO was found to be in compliance with all of the requirements of this act, then the board shall pay the costs of the audit.
However, the pharmacy benefit manager or PSAO being audited shall pay all costs of such audit if such audit reveals any noncompliance with this act.
73-21-165.
(1) Each drug manufacturer shall submit a report to the board no later than the fifteenth day of January, April, July and October with the current wholesale acquisition cost information for the prescription drugs sold in or into the state by that drug manufacturer;
provided, however, the first report due under this subsection shall not be due until October 1, 2025.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 28 (2) Not more than thirty (30) days after an increase in wholesale acquisition cost of forty percent (40%) or greater over the preceding five (5) calendar years or ten percent (10%) or greater in the preceding twelve (12) months for a prescription drug with a wholesale acquisition cost of Seventy Dollars ($70.00) or more for a manufacturer-packaged drug container, a drug manufacturer shall submit a report to the board.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 28 73-21-165.
(1) Each drug manufacturer shall submit a report to the board no later than the fifteenth day of January, April, July and October with the current wholesale acquisition cost information for the prescription drugs sold in or into the state by that drug manufacturer;
provided, however, the first report due under this subsection shall not be due until October 1, 2025.
(2) Not more than thirty (30) days after an increase in wholesale acquisition cost of forty percent (40%) or greater over the preceding five (5) calendar years or ten percent (10%) or greater in the preceding twelve (12) months for a prescription drug with a wholesale acquisition cost of Seventy Dollars ($70.00) or more for a manufacturer-packaged drug container, a drug manufacturer shall submit a report to the board.
(g) The name of each of the drug manufacturer's drugs that lost patent exclusivity in the United States in the previous five (5) calendar years;
S.
and (h) A concise statement of rationale regarding the factor or factors that caused the increase in the wholesale S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 29 acquisition cost, such as raw ingredient shortage or increase in pharmacy benefit manager's or PSAO's rebates.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 29 (g) The name of each of the drug manufacturer's drugs that lost patent exclusivity in the United States in the previous five (5) calendar years;
and (h) A concise statement of rationale regarding the factor or factors that caused the increase in the wholesale acquisition cost, such as raw ingredient shortage or increase in pharmacy benefit manager's or PSAO's rebates.
A drug manufacturer may make the notification pending approval by the United States Food and Drug Administration if commercial availability is expected within three (3) calendar days following the approval.
A drug manufacturer may make the notification pending approval by the United States Food and Drug Administration if commercial S.
(4) On or before October 1st of each year, a pharmacy benefit manager or PSAO providing services for a health care plan shall file a report with the board.
The report must contain the following information for the previous state fiscal year:
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 30 (a) The aggregated rebates, fees, price protection payments, and any other payments collected from each drug manufacturer;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 30 availability is expected within three (3) calendar days following the approval.
(4) On or before October 1st of each year, a pharmacy benefit manager or PSAO providing services for a health care plan shall file a report with the board.
The report must contain the following information for the previous state fiscal year:
(a) The aggregated rebates, fees, price protection payments, and any other payments collected from each drug manufacturer;
(5) Reports submitted by pharmacy benefit managers and PSAOs under this section may not disclose the identity of a specific health benefit plan or enrollee, the identity of a drug manufacturer, the prices charged for specific drugs or classes of drugs, or the amount of any rebates or fees provided for specific drugs or classes of drugs.
(5) Reports submitted by pharmacy benefit managers and PSAOs under this section may not disclose the identity of a specific health benefit plan or enrollee, the identity of a drug manufacturer, the prices charged for specific drugs or classes of S.
(6) On or before October 1st of each year, each health insurer shall submit a report to the board.
The report must contain the following information for the previous two (2) calendar years:
S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 31 (a) Names of the twenty-five (25) most frequently prescribed drugs across all plans;
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 31 drugs, or the amount of any rebates or fees provided for specific drugs or classes of drugs.
(6) On or before October 1st of each year, each health insurer shall submit a report to the board.
The report must contain the following information for the previous two (2) calendar years:
(a) Names of the twenty-five (25) most frequently prescribed drugs across all plans;
73-21-167.
(1) The board shall develop a website to publish information the board receives under this chapter.
The board shall make the website available on the board's website with a dedicated link prominently displayed on the home page, or by a separate, easily identifiable Internet address.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 32 (2) Within sixty (60) days of receipt of reported information under this chapter, the board shall publish the reported information on the website developed under this section.
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 32 73-21-167.
(1) The board shall develop a website to publish information the board receives under this chapter.
The board shall make the website available on the board's website with a dedicated link prominently displayed on the home page, or by a separate, easily identifiable Internet address.
(2) Within sixty (60) days of receipt of reported information under this chapter, the board shall publish the reported information on the website developed under this section.
SECTION 12.
S.
The following shall be codified as Section 73-21-169, Mississippi Code of 1972:
73-21-169.
(1) Pharmacy benefit managers and PSAOs shall also identify to the board any ownership affiliation of any kind with any pharmacy which, either directly or indirectly, through S.
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 PAGE 33 one or more intermediaries:
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS PAGE 33 SECTION 12.
The following shall be codified as Section 73-21-169, Mississippi Code of 1972:
73-21-169.
(1) Pharmacy benefit managers and PSAOs shall also identify to the board any ownership affiliation of any kind with any pharmacy which, either directly or indirectly, through one or more intermediaries:
2677 *SS08/R857CS.1* ~ OFFICIAL ~ 25/SS08/R857CS.1 ST:
2677 *SS36/R857PS* ~ OFFICIAL ~ 25/SS36/R857PS ST:
⬇ Download PDF
View plain text versions (3)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Died In Committee

  2. Referred To State Affairs;Accountability, Efficiency, Transparency

  3. Transmitted To House

  4. Passed

  5. Amendment Failed

  6. Committee Substitute Adopted

  7. Title Suff Do Pass Comm Sub

  8. Referred To Public Health and Welfare

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 16 co-sponsors · 158 not signed on

Sponsors (1)

Co-sponsors (16)

Not signed on (158)

158 members have not signed on to this bill.

Show all 158 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passage

Passed 50 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 13000
Republican 31001
Unaffiliated 6000
Total 50001
% of votes cast 98%0%0%2%
How each member voted (51)
Member Party Vote
Horhn — Yea
Jordan — Yea
Parker — Yea
Polk — Yea
Robinson — Yea
Turner-Ford — Yea
Albert Butler Democrat Yea
Bradford Blackmon Democrat Yea
David Blount Democrat Yea
Derrick T. Simmons Democrat Yea
Gary Brumfield Democrat Yea
Hillman Terome Frazier Democrat Yea
Hob Bryan Democrat Yea
Joseph Thomas Democrat Yea
Juan Barnett Democrat Yea
Reginald Jackson Democrat Yea
Rod Hickman Democrat Yea
Sarita Simmons Democrat Yea
Sollie B. Norwood Democrat Yea
Andy Berry Republican Yea
Angela Burks Hill Republican Yea
Bart Williams Republican Yea
Benjamin Suber Republican Yea
Brian Rhodes Republican Yea
Brice Wiggins Republican Yea
Briggs Hopson Republican Yea
Chad McMahan Republican Yea
Chris Johnson Republican Yea
Chuck Younger Republican Yea
Daniel H. Sparks Republican Yea
Dean Kirby Republican Yea
Dennis DeBar, Jr. Republican Yea
J. Walter Michel Republican Yea
Jason Barrett Republican Yea
Jeff Tate Republican Yea
Jeremy England Republican Not Voting
Joel R. Carter, Jr. Republican Yea
Joey Fillingane Republican Yea
Joseph M. Seymour Republican Yea
Josh Harkins Republican Yea
Kathy L. Chism Republican Yea
Kevin Blackwell Republican Yea
Lydia Graves Chassaniol Republican Yea
Michael McLendon Republican Yea
Mike Thompson Republican Yea
Neil S. Whaley Republican Yea
Nicole Boyd Republican Yea
Philman Ladner Republican Yea
Rita Potts Parks Republican Yea
Scott DeLano Republican Yea
Tyler McCaughn Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 2677?
SB 2677 is sponsored by Rita Potts Parks (Republican), Neil S. Whaley (Republican), Angela Burks Hill (Republican), Chuck Younger (Republican), Parker, Bart Williams (Republican), Andy Berry (Republican), Lydia Graves Chassaniol (Republican), Tyler McCaughn (Republican), Briggs Hopson (Republican), Michael McLendon (Republican), Brian Rhodes (Republican), Jason Barrett (Republican), Albert Butler (Democrat), Joseph M. Seymour (Republican), Nicole Boyd (Republican), and Kevin Blackwell (Republican).
What is the current status of SB 2677?
This bill died with 2025 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 2677?
Track SB 2677 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 2677

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 2677

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →